In vitro evaluation of cytotoxic and inflammatory properties of silica nanoparticles of different sizes in murine RAW 264.7 macrophages
Source abstract
Abstract
The biological response to four well-characterized amorphous silica nanoparticles was investigated in RAW 264.7 macrophages in view of their potential application as drug carriers to sites of inflammation. All silica nanoparticles-induced cell membrane damage, reduced metabolic activity, generated ROS and released various cytokines, but to different extents. Two silica nanoparticles of 34 nm (A and B) with different zetapotentials were more cytotoxic than (aggregated) 11 and 248 nm nanoparticles, while cytokines were mostly induced by the (aggregated) 11 nm and only one of the 34 nm nanoparticles (34A). The results indicate that specific silica nanoparticles may have counterproductive effects, for example when used as carriers of anti-inflammatory drugs. The physicochemical properties determining the response of nanoparticles vary for different responses, implying that a screening approach for the safe development of nanoparticles needs to consider the role of combinations of (dynamic) physicochemical properties and needs to include multiple toxicity endpoints.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nigella sativa pharmacological applications · Moringa oleifera research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Agasti SS, Rana S, Park MH, Kim CK, You CC, Rotello VM (2010) Nanoparticles for detection and diagnosis. Adv Drug Deliv Rev 62(3):316–32810.1016/j.addr.2009.11.004 ↗
2. Akhtar MJ, Ahamed M, Kumar S, Siddiqui H, Patil G, Ashquin M, Ahmad I (2010) Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 276(2):95–10210.1016/j.tox.2010.07.010 ↗
3. Barnes CA, Elsaesser A, Arkusz J, Smok A, Palus J, Lesniak A, Salvati A, Hanrahan JP, Jong WH, Dziubaltowska E et al (2008) Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett 8(9):3069–307410.1021/nl801661w ↗
4. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112(43):13608–1361910.1021/jp712087m ↗
5. Chauhan V, Breznan D, Goegan P, Nadeau D, Karthikeyan S, Brook JR, Vincent R (2004) Effects of ambient air particles on nitric oxide production in macrophage cell lines. Cell Biol Toxicol 20(4):221–23910.1023/B:CBTO.0000038461.02222.95 ↗
6. Chen Y, Xue Z, Zheng D, Xia K, Zhao Y, Liu T, Long Z, Xia J (2003) Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr Gene Ther 3(3):273–27910.2174/1566523034578339 ↗
7. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13(7):851–85610.1038/nm1603 ↗
8. Choi J, Zhang Q, Reipa V, Wang NS, Stratmeyer ME, Hitchins VM, Goering PL (2009) Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29(1):52–6010.1002/jat.1382 ↗
9. Choi J, Zheng Q, Katz HE, Guilarte TR (2010) Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect 118(5):589–59510.1289/ehp.0901534 ↗
10. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12):1912–191910.1016/j.biomaterials.2007.12.037 ↗
11. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ (2007) Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100(1):303–31510.1093/toxsci/kfm217 ↗
12. EFSA (2009) Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA J 1150:1–72
13. Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18(6):565–57110.1016/j.copbio.2007.11.008 ↗
14. Hamoir J, Nemmar A, Halloy D, Wirth D, Vincke G, Vanderplasschen A, Nemery B, Gustin P (2003) Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties. Toxicol Appl Pharmacol 190(3):278–28510.1016/S0041-008X(03)00192-3 ↗
15. Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG (2010) ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7(1):3610.1186/1743-8977-7-36 ↗
16. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847–85610.1038/ni.1631 ↗
17. Jarzyna PA, Gianella A, Skajaa T, Knudsen G, Deddens LH, Cormode DP, Fayad ZA, Mulder WJ (2010) Multifunctional imaging nanoprobes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(2):138–15010.1002/wnan.72 ↗
18. Johnston CJ, Driscoll KE, Finkelstein JN, Baggs R, O’Reilly MA, Carter J, Gelein R, Oberdorster G (2000) Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci 56(2):405–41310.1093/toxsci/56.2.405 ↗
19. Kang JL, Moon C, Lee HS, Lee HW, Park EM, Kim HS, Castranova V (2008) Comparison of the biological activity between ultrafine and fine titanium dioxide particles in RAW 264.7 cells associated with oxidative stress. J Toxicol Environ Health A 71(8):478–48510.1080/15287390801906675 ↗
20. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH (2010) The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31(32):8350–836110.1016/j.biomaterials.2010.07.045 ↗
21. Lesniak A, Campbell A, Lynch I, Salvati A, Dawson KA (2010) Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31(36):9511–951810.1016/j.biomaterials.2010.09.049 ↗
22. Lucarelli M, Gatti AM, Savarino G, Quattroni P, Martinelli L, Monari E, Boraschi D (2004) Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Netw 15(4):339–346
23. Lynch I, Salvati A, Dawson KA (2009) Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4(9):546–54710.1038/nnano.2009.248 ↗
24. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T, Tsunoda S, Tsutsumi Y et al (2010) The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials 31(26):6833–684210.1016/j.biomaterials.2010.05.036 ↗
25. Moulari B, Pertuit D, Pellequer Y, Lamprecht A (2008) The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Biomaterials 29(34):4554–456010.1016/j.biomaterials.2008.08.009 ↗
26. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T et al (2010) Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 65(3):199–201
27. Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH (2009) Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5(7):846–85310.1002/smll.200800461 ↗
28. Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, Pfaller T, Kohl Y, Ooms D, Favilli F et al (2011) Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol 8(1):810.1186/1743-8977-8-8 ↗
29. Park MVDZ, Annema W, Salvati A, Lesniak A, Elsaesser A, Barnes C, McKerr G, Howard CV, Lynch I, Dawson KA et al (2009a) In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol 240:108–11610.1016/j.taap.2009.07.019 ↗
30. Park MVDZ, Lankveld DPK, van Loveren H, de Jong W (2009b) The status of in vitro toxicity studies in risk assessment of nanomaterials. Nanomedicine 4(6):669–68510.2217/nnm.09.40 ↗
31. Park MVDZ, Verharen HW, Zwart E, Hernandez LG, van Benthem J, Elsaesser A, Barnes C, McKerr G, Howard CV, Salvati A et al (2011) Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology 5:168–18110.3109/17435390.2010.506016 ↗
32. Pfaller T, Puntes VF, Casals E, Duschl A, Oostingh GJ (2009) In vitro investigation of immunomodulatory effects caused by engineered inorganic nanoparticles—the impact of experimental design and cell choice. Nanotoxicology 3(1):46–5910.1080/17435390802546071 ↗
33. Powell JJ, Faria N, Thomas-McKay E, Pele LC (2010) Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34(3):J226–J23310.1016/j.jaut.2009.11.006 ↗
34. RIVM (2009) PROAST: Software for dose-response modeling and benchmark dose analysis. Available from: www.proast.nl
35. Roy I, Stachowiak MK, Bergey EJ (2008) Nonviral gene transfection nanoparticles: function and applications in the brain. Nanomedicine 4(2):89–9710.1016/j.nano.2008.01.002 ↗
36. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, Danscher G (2007) Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:1010.1186/1743-8977-4-10 ↗
37. Sayes CM, Reed KL, Warheit DB (2007) Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97(1):163–18010.1093/toxsci/kfm018 ↗
38. Shi Y, Yadav S, Wang F, Wang H (2010) Endotoxin promotes adverse effects of amorphous silica nanoparticles on lung epithelial cells in vitro. J Toxicol Environ Health A 73(11):748–75610.1080/15287391003614042 ↗
39. Slob W (2002) Dose-response modeling of continuous endpoints. Toxicol Sci 66(2):298–31210.1093/toxsci/66.2.298 ↗
40. Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L (2010) Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 7(1):2210.1186/1743-8977-7-22 ↗
41. Stöber W, Fink A, Bohn E (1968) Controlled growth of monodisperse silica spheres in the micron size range. J ColloidInterface Sci 26(1):62–6910.1016/0021-9797(68)90272-5 ↗
42. Stone V, Johnston H, Schins RP (2009) Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39(7):613–62610.1080/10408440903120975 ↗
43. Tao Z, Morrow MP, Asefa T, Sharma KK, Duncan C, Anan A, Penefsky HS, Goodisman J, Souid AK (2008) Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett 8(5):1517–152610.1021/nl080250u ↗
44. Tao Z, Toms BB, Goodisman J, Asefa T (2009) Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 22(11):1869–188010.1021/tx900276u ↗
45. Thomassen LC, Aerts A, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Napierska D, Hoet PH, Kirschhock CE, Martens JA (2010) Synthesis and characterization of stable monodisperse silica nanoparticle sols for in vitro cytotoxicity testing. Langmuir 26(1):328–33510.1021/la902050k ↗
46. Ulbrich W, Lamprecht A (2010) Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface 7(Suppl 1):S55–S6610.1098/rsif.2009.0285.focus ↗
47. van Maanen JM, Borm PJ, Knaapen A, van Herwijnen M, Schilderman PA, Smith KR, Aust AE, Tomatis M, Fubini B (1999) In vitro effects of coal fly ashes: hydroxyl radical generation, iron release, and DNA damage and toxicity in rat lung epithelial cells. Inhal Toxicol 11(12):1123–114110.1080/089583799196628 ↗
48. Veranth JM, Kaser EG, Veranth MM, Koch M, Yost GS (2007) Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 4:210.1186/1743-8977-4-2 ↗
49. Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ, Quesenberry RD, Bandyopadhyay S, Teeguarden JG, Pounds JG, Thrall BD (2009) Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol Sci 107(2):553–56910.1093/toxsci/kfn250 ↗
50. Wottrich R, Diabate S, Krug HF (2004) Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 207(4):353–36110.1078/1438-4639-00300 ↗
51. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6(8):1794–180710.1021/nl061025k ↗
52. Yamamoto A, Honma R, Sumita M, Hanawa T (2004) Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 68(2):244–25610.1002/jbm.a.20020 ↗
53. Yang A, Liu W, Li Z, Jiang L, Xu H, Yang X (2010) Influence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation. J Nanosci Nanotechnol 10(1):622–62810.1166/jnn.2010.1738 ↗
54. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J (2010) Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci USA 107(45):19449–1945410.1073/pnas.1008155107 ↗